WellTheory, a leading whole-person care platform for autoimmune disease, announced the close of $5 million in new funding and the rollout of its AI tools Care Hub and Care Scribe across its care operations. New investors Samsung Next, Opal Ventures, and Up2 Fund joined the funding round, with continued support from existing investors Accel, OVO Fund, and BoxGroup.
These milestones represent a major leap forward in the company’s mission to make autoimmune care more accessible, scalable, and effective for the 50 million Americans navigating these chronic conditions like rheumatoid arthritis, lupus and multiple sclerosis.
WellTheory’s Care Scribe, which is the company’s proprietary AI assistant, now supports its Care Team by attending member sessions, transcribing conversations, and drafting follow-up notes and personalized Care Plans all for provider review and customization. And the tool has reduced provider prep and documentation time by 65%, enabling a more efficient and focused care experience.
Along with Care Scribe, the newly launched Care Hub acts as the unified command center for WellTheory’s providers, aggregating member data, session history, and lab insights in one place. And with dynamic workflows tailored to each session type, the Care Hub streamlines pre- and post-session tasks and enables automated compliance tracking. The result is a smoother care journey for providers and members.
This meta-intelligence will power a personalized and proactive experience for members, surfacing symptom patterns, optimizing interventions, and enabling the Care Team to deliver precision support at scale. And by connecting the dots across a fragmented care journey, WellTheory aims to not only reduce the burden of autoimmune disease, but also to fundamentally reimagine how it’s managed.
With the Care Hub and Care Scribe fully deployed, WellTheory is focused on what comes next: utilizing its growing ecosystem of data, including session transcripts, lab results, symptom tracking, lifestyle inputs, and provider insights, to build a next-generation intelligence layer across the member journey. And future product investments include deeper automation in areas like lab workflows and scheduling, expanded analytics and care optimization tools for providers, and a reimagined member-facing experience grounded in personalization, guidance, and long-term engagement.
What the funding will be used for: The new funding round will advance WellTheory’s expansion into the employer and health plan markets, and accelerate the development of its AI-powered care infrastructure for providers and members.
KEY QUOTES:
“AI is no longer a nice-to-have in care delivery — its essential infrastructure. This new round of funding is allowing us to double down on our AI strategy, streamline the most time-consuming parts of care, and expand into new markets. We’re leading the charge in making whole-person, root-cause care more accessible, personalized, and effective — and bringing it to scale through our growing partnerships with employers and health plans.”
Ellen Rudolph, CEO and Co-founder of WellTheory
“Care delivery for patients with autoimmune disease is incredibly complex—our team built these tools to help give our Care Team time back for what matters most: supporting our members. With WellTheory’s Care Hub and Care Scribe, we’re building the modern infrastructure autoimmune care has always needed — intelligent, integrated systems that streamline repetitive tasks, amplify what makes care human, and equip our team to deliver more personalized, responsive support at scale.”
Claire Rudolph, Co-Founder and Head of Product at WellTheory
